OBJECTIVE: To evaluate the evidence for prenatal corticosteroid use in low- and middle-income countries and to make recommendations regarding implementation and further research. METHODS: Studies and meta-analyses on prenatal corticosteroids relevant to low- and middle-income countries were identified and reviewed at the Maternal and Child Health Integrated Project (MCHIP) Antenatal Corticosteroid Conference held in Washington on October 19, 2010. RESULTS: There is strong evidence regarding the effectiveness of prenatal corticosteroid use in hospitals in high- and middle-income countries, usually in settings with high-level newborn care. For births occurring in hospitals in low-income countries without high-level neonatal care or for births outside hospitals, no studies have been conducted to evaluate prenatal corticosteroid use. The efficacy and safety of prenatal corticosteroid use in these settings must be evaluated. CONCLUSIONS: The conference working group recommended expanding the use of prenatal corticosteroids in hospitals with high-level newborn care in low-income countries. For other low-income country settings, further research regarding efficacy and safety should precede the widespread introduction of prenatal corticosteroids.
OBJECTIVE: To evaluate the evidence for prenatal corticosteroid use in low- and middle-income countries and to make recommendations regarding implementation and further research. METHODS: Studies and meta-analyses on prenatal corticosteroids relevant to low- and middle-income countries were identified and reviewed at the Maternal and Child Health Integrated Project (MCHIP) Antenatal Corticosteroid Conference held in Washington on October 19, 2010. RESULTS: There is strong evidence regarding the effectiveness of prenatal corticosteroid use in hospitals in high- and middle-income countries, usually in settings with high-level newborn care. For births occurring in hospitals in low-income countries without high-level neonatal care or for births outside hospitals, no studies have been conducted to evaluate prenatal corticosteroid use. The efficacy and safety of prenatal corticosteroid use in these settings must be evaluated. CONCLUSIONS: The conference working group recommended expanding the use of prenatal corticosteroids in hospitals with high-level newborn care in low-income countries. For other low-income country settings, further research regarding efficacy and safety should precede the widespread introduction of prenatal corticosteroids.
Authors: Gary L Darmstadt; Zulfiqar A Bhutta; Simon Cousens; Taghreed Adam; Neff Walker; Luc de Bernis Journal: Lancet Date: 2005 Mar 12-18 Impact factor: 79.321
Authors: R C Pattinson; J D Makin; M Funk; S D Delport; A P Macdonald; K Norman; G Kirsten; C Stewart; D Woods; G Moller; E Coetzee; P Smith; J Anthony; M Schoon; S Grobler Journal: S Afr Med J Date: 1999-08
Authors: Fernando Althabe; José M Belizán; Elizabeth M McClure; Jennifer Hemingway-Foday; Mabel Berrueta; Agustina Mazzoni; Alvaro Ciganda; Shivaprasad S Goudar; Bhalachandra S Kodkany; Niranjana S Mahantshetti; Sangappa M Dhaded; Geetanjali M Katageri; Mrityunjay C Metgud; Anjali M Joshi; Mrutyunjaya B Bellad; Narayan V Honnungar; Richard J Derman; Sarah Saleem; Omrana Pasha; Sumera Ali; Farid Hasnain; Robert L Goldenberg; Fabian Esamai; Paul Nyongesa; Silas Ayunga; Edward A Liechty; Ana L Garces; Lester Figueroa; K Michael Hambidge; Nancy F Krebs; Archana Patel; Anjali Bhandarkar; Manjushri Waikar; Patricia L Hibberd; Elwyn Chomba; Waldemar A Carlo; Angel Mwiche; Melody Chiwila; Albert Manasyan; Sayury Pineda; Sreelatha Meleth; Vanessa Thorsten; Kristen Stolka; Dennis D Wallace; Marion Koso-Thomas; Alan H Jobe; Pierre M Buekens Journal: Lancet Date: 2014-10-15 Impact factor: 79.321
Authors: Grace Liu; Joel Segrè; A Gülmezoglu; Matthews Mathai; Jeffrey M Smith; Jorge Hermida; Aline Simen-Kapeu; Pierre Barker; Mercy Jere; Edward Moses; Sarah G Moxon; Kim E Dickson; Joy E Lawn; Fernando Althabe Journal: BMC Pregnancy Childbirth Date: 2015-09-11 Impact factor: 3.007
Authors: Fernando Althabe; Mabel Berrueta; Jennifer Hemingway-Foday; Agustina Mazzoni; Carolina Astoul Bonorino; Andrea Gowdak; Luz Gibbons; M B Bellad; M C Metgud; Shivaprasad Goudar; Bhalchandra S Kodkany; Richard J Derman; Sarah Saleem; Samina Iqbal; Syed Hasan Ala; Robert L Goldenberg; Elwyn Chomba; Albert Manasyan; Melody Chiwila; Edna Imenda; Florence Mbewe; Antoinette Tshefu; Victor Lokomba; Carl L Bose; Janet Moore; Sreelatha Meleth; Elizabeth M McClure; Marion Koso-Thomas; Pierre Buekens; José M Belizán Journal: PLoS One Date: 2015-03-30 Impact factor: 3.240
Authors: Stanley Mwita; Eveline Konje; Benjamin Kamala; Angelina Izina; Semvua Kilonzo; Andrew Kigombola; Karol J Marwa; Mary Jande; Deborah Dewey Journal: PLoS One Date: 2021-07-22 Impact factor: 3.240
Authors: Mabel Berrueta; Jennifer Hemingway-Foday; Vanessa R Thorsten; Robert L Goldenberg; Waldemar A Carlo; Ana Garces; Archana Patel; Sarah Saleem; Omrana Pasha; Elwyn Chomba; Patricia L Hibberd; Nancy F Krebs; Shivaprasad Goudar; Richard J Derman; Fabian Esamai; Edward A Liechty; Janet L Moore; Elizabeth M McClure; Marion Koso-Thomas; Pierre M Buekens; José M Belizán; Fernando Althabe Journal: Reprod Health Date: 2016-05-27 Impact factor: 3.223